Skip to main content
. 2004 Aug;58(2):178–183. doi: 10.1111/j.1365-2125.2004.02102.x

Table 2.

Comparison of characteristics between patients on one antipsychotic (NP) and patients on more than one antipsychotic (P)

NP (n = 1302) P (n = 1097) Test statistic P
Age (years) t = −7.81,d.f. = 2396 <0.001
Mean 41.66 45.93
SD 13.74 12.82
Daily CPZeq (mg day−1) 411.47 983.10 Z = −25.94 <0.001
Duration of illness* χ2 = 68.28 <0.001
  <1 year 78 (6.00) 33 (3.00)
  1–5 years 199 (15.30) 103 (9.40)
  6–10 years 251 (19.30) 152 (13.90)
  11–20 years 369 (28.30) 324 (29.50)
  >20 years 405 (31.10) 485 (44.20)
OR (95% CI) P
Gender*
  Female 606 (46.50) 452 (41.20) 1.00
  Male 696 (53.50) 645 (58.80) 1.24 (1.06, 1.46) <0.01
Treatment setting
  General hospital 363 (72.10) 245 (22.30) 1.00
  Psychiatric hospital 939 (27.90) 852 (77.70) 1.34 (1.11, 1.62) <0.01
First admission*
  No 1058 (81.26) 898 (81.90)
  Yes 244 (18.74) 199 (18.10) NS
Medication use*
  Atypical antipsychotic 620 (47.60) 472 (43.00) 0.83 (0.71, 0.98) <0.05
  Anticholinergic drugs 678 (52.10) 850 (77.50) 3.17 (2.65, 3.79) <0.001

CPZeq, Chlorpromazine equivalents.

*

The figures are number of patients with percentage in parentheses.